MS Toronto 2026

Menu

WELCOME & COMMITTEE

Welcome to MSToronto2026

Dear Colleagues,

We are pleased to invite you to MSToronto2026, the 10th Joint ACTRIMS-ECTRIMS Meeting, taking place October 21–23, 2026, at the Metro Toronto Convention Centre in Toronto, Canada.

Every three years, ACTRIMS and ECTRIMS come together to host a joint meeting. MSToronto2026 will mark the 10th such gathering, uniting researchers, clinicians, healthcare practitioners, and industry partners from around the world to share knowledge, build connections, and explore the latest advancements in multiple sclerosis and other demyelinating diseases.

Guided by the theme “Unifying Multiple Sclerosis,” this meeting reflects scientific progress in the field, recognizing that MS is one disease—affecting people of all races and geographies—diagnosed within a unified framework and described through a unified clinical course.

The scientific program will include:

  • Plenary lectures from leading experts
  • Scientific and educational sessions on cutting-edge MS research, diagnostics, and treatment approaches
  • Platform presentations highlighting novel discoveries and clinical applications
  • Poster sessions showcasing groundbreaking work
  • Satellite symposia featuring industry innovation
  • And numerous networking opportunities to build collaboration and community

We look forward to continuing important initiatives at MSToronto2026, including a Pre-Day focused on rare diseases connected with MS and a Patient Community Day designed to foster meaningful dialogue between the scientific community and those living with MS.

Set against the backdrop of Toronto, a city celebrated for its multicultural diversity, vibrant arts scene, and world-class attractions, MSToronto2026 promises to be an exceptional gathering that advances both knowledge and clinical practice.

We acknowledge that the land on which we will meet is the traditional territory of many nations, including the Mississaugas of the Credit, the Anishnabeg, the Chippewa, the Haudenosaunee, and the Wendat peoples, and is now home to many diverse First Nations, Inuit, and Métis peoples.

On behalf of the ACTRIMS and ECTRIMS Board of Directors and the Scientific Program Committee, we appreciate your participation and look forward to an inspiring and impactful meeting.

Sincerely,

Daniel Ontaneda
Scientific Program Committee Chair

ACTRIMS Director

Olga Ciccarelli
Scientific Program Committee Vice Chair

ECTRIMS Vice President

Scientific Program Committee

  • Daniel Ontaneda, Chair, Cleveland Clinic (US)
  • Olga Ciccarelli, Vice Chair, UCL Queen Square Institute of Neurology (UK)
  • Gabriel Bsteh, Medical University of Vienna (AT)
  • Jeffrey Cohen, Cleveland Clinic (US)
  • Fiona Costello, University of Calgary (CA)
  • Mark Freedman, University of Ottawa (CA)
  • Myla Goldman, Virginia Commonwealth University (US)
  • Cristina Granziera, University of Basel (CH)
  • Matilde Inglese, University of Genoa / S. Martino Hospital (IT)
  • Catherine Larochelle, Université de Montréal (CA)
  • Robert Naismith, Washington University in St. Louis (US)
  • Jiwon Oh, University of Toronto (CA)
  • Daniel Reich, National Institutes of Health, National Institute of Neurological Disorders and Stroke (US)
  • Jaume Sastre-Garriga, Vall d’Hebron Hospital – CEMCAT (ES)
  • Benjamin Segal, The Ohio State University (US)
  • Bruno Stankoff, Hôpital Pitié Salpêtrière (FR)
  • Emmanuelle Waubant, University of California, San Francisco (US)
  • Frauke Zipp, University Medical Center of the Johannes Gutenberg University Mainz (DE)